Should I Buy ECBK? ECBK 2026 Analysis

Should You Buy ECB Bancorp Inc (ECBK) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Hold

Latest Price

18.210

1 Day change

0.39%

52 Week Range

18.490

Analysis Updated At

2026/02/04

Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Not a good buy right now for an impatient entry: price is extended/overbought (RSI_6 ~90) and sitting just below near-term resistance (R1 18.28), which worsens immediate risk/reward.
Trend is bullish (SMA_5 > SMA_20 > SMA_200 and MACD expanding), so this is a quality watchlist name, but the setup favors waiting for a pullback rather than chasing.
Insider buying is a meaningful positive, but without a proprietary buy signal today and with no fresh news catalyst, the edge for buying immediately is weak.

Technical Analysis

Trend: Bullish structure with stacked moving averages (SMA_5 > SMA_20 > SMA_200) indicating sustained upward momentum.
Momentum: MACD histogram +0.0944 and expanding, supporting the uptrend continuation bias.
Overbought: RSI_6 at 90.187 signals an overstretched move; probability of near-term mean reversion/pullback is elevated.
Levels: Pivot 17.78; Support S1 17.279 (then S2 16.97). Resistance R1 18.28 (then R2 18.589). Current price 18.22 is pressing into resistance.
Pattern-based forward view: Similar-pattern stats suggest ~80% chance of modest upside (+0.53% next day, +2.98% next week, +9.3% next month), but the near-term entry is still technically “crowded.”
Intellectia Proprietary Trading Signals
AI Stock Picker: no signal on given stock today.
SwingMax: No signal on given stock recently.

Positive Catalysts

- Insiders are buying: buying amount up ~197.68% over the last month, a strong confidence signal.
- Strong uptrend confirmed by moving averages and positive MACD.
- Latest quarter showed sharp YoY growth in revenue, net income, and EPS, supporting fundamental momentum.

Neutral/Negative Catalysts

- Very overbought short-term (RSI_6 ~90), increasing odds of a pullback right after entry.
- Price is near resistance (18.28/18.589); upside may be capped short-term unless it breaks out cleanly.
- No news in the recent week: limited event-driven catalyst to justify chasing at an extended level.
- Hedge funds neutral: no reinforcing institutional “trend” signal in the provided data.

Financial Performance

Latest quarter: 2025/Q3.
Revenue: 8,542,000 (+33.68% YoY) showing solid top-line acceleration.
Net Income: 2,439,000 (+115.27% YoY) indicating strong profitability improvement.
EPS: 0.29 (+107.14% YoY) confirming earnings momentum.
Margin line provided shows no change (gross margin listed as 0), so margin trend can’t be validated from the snapshot.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst rating or price target change data was provided, so a Wall Street pros/cons consensus view cannot be confirmed from this dataset.
No recent politician/congress trading data available in the last 90 days (no identifiable influential-figure activity from provided data).

Analyst Rating

Wall Street analysts forecast ECBK stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ECBK is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

Buy

Hold

Sell

Current: 18.140

Low

Averages

High